NCT03573960 2026-03-06
A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer
Eisai Inc.
Phase 4 Completed
Clinical Trials
3 trialsNCT06073223 2026-02-17
Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer
University of Michigan Rogel Cancer Center
Phase NA Completed
NCT04593277 2026-01-23
Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study
Fred Hutchinson Cancer Center
Phase NA Completed